Priscila Suguita

Priscila Suguita

Auto-generated profile, based on publicly available information

Priscila Suguita

Departamento de Pediatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2021 in Clinics
Verified
Journal Article
Open access
TFThais T. Fink
Thais T. Fink
HMHeloisa H.S. Marques
Heloisa H.S. Marques
BGBruno Gualano
Bruno Gualano
LLLivia Lindoso
Livia Lindoso
VBVera Bain
Vera Bain
YZYingying Zheng
Yingying Zheng
To prospectively evaluate demographic, anthropometric and health-related quality of life (HRQoL) in pediatric patients with laboratory-confirmed coronavirus disease 2019 (COVID-19) This was a longitudinal observational study of surviving pediatric post-COVID-19 patients (n=53) and pediatric subjects without laboratory-confirmed COVID-19 included as controls (n=52) was performed. The median duration between COVID-19 diagnosis (n=53) and follow-up was 4.4 months (0.8-10.7). Twenty-three of 53 (43%) patients reported at least one persistent symptom at the longitudinal follow-up visit and 12/53 (23%) had long COVID-19, with at least one symptom lasting for >12 weeks. The most frequently reported symptoms at the longitudinal follow-up visit were headache (19%), severe recurrent headache (9%), tiredness (9%), dyspnea (8%), and concentration difficulty (4%). At the longitudinal follow-up visit, the frequencies of anemia (11% versus 0%, p=0.030), lymphopenia (42% versus 18%, p=0.020), C-reactive protein level of >30 mg/L (35% versus 0%, p=0.0001), and D-dimer level of >1000 ng/mL (43% versus 6%, p=0.0004) significantly reduced compared with baseline values. Chest X-ray abnormalities (11% versus 2%, p=0.178) and cardiac alterations on echocardiogram (33% versus 22%, p=0.462) were similar at both visits. Comparison of characteristic data between patients with COVID-19 at the longitudinal follow-up visit and controls showed similar age (p=0.962), proportion of male sex (p=0.907), ethnicity (p=0.566), family minimum monthly wage (p=0.664), body mass index (p=0.601), and pediatric pre-existing chronic conditions (p=1.000). The Pediatric Quality of Live Inventory 4.0 scores, median physical score (69 [0-100] versus 81 [34-100], p=0.012), and school score (60 [15-100] versus 70 [15-95], p=0.028) were significantly lower in pediatric patients with COVID-19 at the longitudinal follow-up visit than in controls. Pediatric patients with COVID-19 showed a longitudinal impact on HRQoL parameters, particularly in physical/school domains, reinforcing the need for a prospective multidisciplinary approach for these patients. These data highlight the importance of closer monitoring of children and adolescents by the clinical team after COVID-19.

1 January 2022 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
MPMaria Fernanda Bádue Pereira
Maria Fernanda Bádue Pereira
PSPriscila Suguita
Priscila Suguita
NLNadia Litvinov
Nadia Litvinov
SFSylvia Costa Lima Farhat
Sylvia Costa Lima Farhat
CPCamila Sanson Yoshino de Paula
Camila Sanson Yoshino de Paula
HMHeloisa Helena de Sousa Marques
Heloisa Helena de Sousa Marques
This study aims to assess COVID-19 and other respiratory viruses in pediatric patients. Between April 17 and September 30, 2020, we collected 1,566 respiratory samples from 1,044 symptomatic patients who were younger than 18 years old to assess SARS-CoV-2 infection. Of these, 919 were analyzed for other respiratory pathogens (ORP). Patients with laboratory-confirmed COVID-19 or ORP were included. We evaluated 76 pediatric COVID-19 infections and 157 other respiratory virus infections. Rhinovirus occurred in 132/157 (84%). COVID-19 patients who were significantly older, had more fevers, headaches and pneumonia than those with ORP. The median white blood cell count was lower in patients with SARS-CoV-2 than in those with ORP (6,470 versus 8,170; p=0.02). COVID-19 patients had significantly worse symptoms than those with ORP.

4 July 2025 in Human Immunology
Verified
Journal Article
Closed access
ISIsabela Silva-Avelar
Isabela Silva-Avelar
BSBruna Danielly Santos-Silva
Bruna Danielly Santos-Silva
YZYingying Zheng
Yingying Zheng
AFArthur E.F. Ferreira
Arthur E.F. Ferreira
GGGuilherme S. Gonçalves
Guilherme S. Gonçalves
SCSimone Corrêa-Silva
Simone Corrêa-Silva


14 January 2026 in Journal of Infection
Verified
Journal Article
Open access
VBVera Bain
Vera Bain
ISIsabela Silva-Avelar
Isabela Silva-Avelar
SCSimone Correa-Silva
Simone Correa-Silva
OMOlivia M. Matsuo
Olivia M. Matsuo
YZYingying Zheng
Yingying Zheng
MPMaria Fernanda Bádue Pereira
Maria Fernanda Bádue Pereira